Biocon's novel anti-psoriasis biotech drug Itolizumab released in India
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2013
After geting the regulatory approval in early 2013, Biocon, India's number two biotech company by revenues, released the...Read more
Bioventus gets global rights for Pfizer's bone portfolio
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2013
Singapore: Bioventus, which specializes in active orthopaedic healing, has acquired exclusive, worldwide license to Pfiz...Read more
Merck to halt Parkinson's trial due to lack of efficacy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013
Singapore: Merck, known as Merck Sharp & Dohme (MSD) outside the US and Canada, provided update on its clinical prog...Read more
Hong Kong to host international TCM exhibition, conference
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2013
Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...Read more
Viralytics melanoma trial meets primary endpoint
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013
Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...Read more
Oramed submits pre-IND to FDA for exenatide
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013
Singapore: Oramed Pharmaceuticals, developer of oral drug delivery systems, submitted a pre-investigational new drug (pr...Read more
GE fortifies iPS cell-derived cellular assay avenue
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
Singapore: GE Healthcare Life Sciences has licensed Cellular Dynamics International, US-based commercial producer of hum...Read more
Daiichi's thrombosis drug meets primary endpoint
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2013
Singapore: Global phase III clinical trial of once-daily edoxaban for the treatment of acute symptomatic deep vein throm...Read more
J&J, Pfizer halt phase III trial of Alzheimer's drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2012
Singapore: Johnson & Johnson (J&J) discontinued phase III clinical development of bapineuzumab intravenous (IV) ...Read more
Evotec acquires Sanofi's drug discovery site
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Dec, 2014
Singapore: German firm Evotec has acquired Sanofi's drug discovery operation in Toulouse to build an European centre of ...Read more
FDA breakthrough for Roche's MS drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2016
Roche has announced that the US Food and Drug Administration (US FDA) has granted Breakthrough Therapy Designation for t...Read more
Prima BioMed's immunotherapeutic drug secures Japanese patent
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 May, 2016
May 3, 2016: Australia-based Prima BioMed Ltd has announced that the company has been granted patent number 5908210 enti...Read more
MD Anderson, Astellas collaborate to develop new drug for Acute Myeloid Leukemia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Apr, 2015
Japanese pharma giant Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center has signed an option ag...Read more
Merck Millipore appoints Dr Udit Batra as CEO and President
Drug Discovery | Influencers | By BioSpectrum Bureau | 2 Comment | 15 Apr, 2014
Singapore: Merck Millipore, the Life Science division of Merck, has appointed Dr Udit Batra as its new President and CEO...Read more
US Pharmacopeial convention expands in China
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 13 Jan, 2014
Singapore: US Pharmacopeial Convention (USP), a nonprofit global health organization that creates and promotes quality s...Read more
China's Adagene raises $28 million
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2016
Singapore: Adagene, China based antibody discovery and development company, has raised USD28 million Series B financing ...Read more
Merck, China firm to co-develop DNA repair drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013
‎Singapore: Merck Serono, the biopharmaceutical division of Merck, has signed a global licensing, co-development, ...Read more
Pneumonia kills a 5-year-old child every 30 secs: UN
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013
Singapore: Pneumonia remains the single biggest killer of children under the age of five globally, claiming the lives of...Read more